News for Piramal Enterprises Ltd. Piramal Enterprises Q3 Profit: Rs 39 cr, RBI Approves Name Change Piramal Enterprises reported a net profit of Rs 39 crore in Q3, a turnaround from last year's loss.

OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. The company said, “We have also been ...

Robert F. Kennedy Jr. accused Sen. Bernie Sanders of being in the pocket of the pharmaceutical industry during a tense exchange at his Health and Human Services confirmation hearing Thursday, Sky News ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

Piramal Pharma Ltd. announced a net profit of ₹3.7 crore in Q3 FY25, against ₹10.1 crore in the corresponding period in FY24, after decreasing 63.4% YoY. Operating revenues of ₹2,204.2 crore ...

Nandini Piramal, chairperson of Piramal Pharma, said, FY25 so far has been a steady year for the Company with revenue growth of 14% and EBITDA growing at 20%. Our CDMO business continues to deliver ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2024 ...

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 * global development and manufacturing facilities and a global ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...